News zum Sektor Gesundheit aus Japan

Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1545 Aktien zum Sektor Gesundheit bekannt.

>Gesundheit News Japan
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belarus
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldau
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

01.05.26 - 16:30	Olympus and Canon Introduce the Aplio i800 EUS Premium Ultrasound System in the U.S. (PR Newswire)
	Advancing Endoscopic Ultrasound Imaging to Support Early, Informed Clinical Decision‑Making TOKYO and TUSTIN, Calif., May 1, 2026 /PRNewswire/ -- Olympus Corporation and Canon Medical Systems USA, Inc. today announced the U.S. launch of the Aplio i800 EUS premium ultrasound system.......

01.05.26 - 09:01	M3, Inc. Reports Increase In Full Year Profit (AFX)
	TOKYO (dpa-AFX) - M3, Inc. (4YC.F) reported earnings for its full year that Increased, from last yearThe company's bottom line came in at JPY49.100 billion, or JPY72.50 per share. This compares wi......

01.05.26 - 08:39	Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 (GlobeNewswire EN)
	Tokyo, Japan and Cambridge, UK, 1 May 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2026. The full report can be found here....

30.04.26 - 17:15	Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? (Zacks)
	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks....

30.04.26 - 12:24	UK Fund AVI Wants Chairman of Japan Drugmaker Rohto to Leave (Bloomberg)
	Asset Value Investors Ltd. is calling for the chairman of Rohto Pharmaceutical Co. to step down from the Japanese drugmaker's board of directors, in the latest sign that activist shareholders will stay busy this year....

30.04.26 - 07:24	HOYA Corporation Bottom Line Rises In Q4 (AFX)
	TOKYO (dpa-AFX) - HOYA Corporation (HYB.F) revealed a profit for its fourth quarter that Increased, from the same period last yearThe company's earnings totaled JPY54.220 billion, or JPY160.77 per......

29.04.26 - 12:00

Leqembi® annual sales exceed EUR 500 million – second sales milestone achieved (Cision)

Stockholm, Sweden, April 29, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the global sales of Leqembi surpassed EUR 500 million in Eisai's fiscal year 2025 (April 2025 – March 2026), triggering a second sales-related milestone payment of EUR 20 million to BioArctic. Leqembi is the result of a long-standing collaboration between BioArctic and Eisai, and the antibody was originally developed by BioArctic based on the work of Professor Lars Lannfelt and his discovery of the Arctic mutation in Alzheimer's disease. Eisai is responsible for...

29.04.26 - 12:00

Sales of Leqembi® totaled 26.2 billion yen in the first quarter 2026 (Cision)

Stockholm, Sweden, April 29, 2026 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the first quarter 2026, in conjunction with their partner Biogen's first quarter report. In total, sales of JPY 26.2 billion were recorded in the period. This results in a royalty to BioArctic amounting to SEK 161 million, which is an increase of approximately 68 percent compared to the royalty recorded by BioArctic for the first quarter 2025. Eisai's results for their fourth quarter and full year FY2025 (April 2025 - March 2026)...

28.04.26 - 17:16	Olympus Receives FDA Clearance for POWERSEAL™ Open Extended Jaw Device (PR Newswire)
	Fourth Design Introduced in the POWERSEAL Advanced Bipolar Surgical Energy Portfolio Offers Surgeons an Additional Option for Open Surgery WESTBOROUGH, Mass., April 28, 2026 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives......

28.04.26 - 15:18	Protagonist Therapeutics: Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration (Accesswire)
	Opt-out election makes Protagonist eligible for $200 million upon exercise and an additional $200 million upon FDA approval of rusfertide for polycythemia veraApproval would also trigger a $75 mill......

28.04.26 - 13:48	Zentek Ltd.: Albany Graphite Launches Year Two Environmental and Social Baseline Program with ERM and Constance Lake First Nation (Newsfile)
	Guelph, Ontario--(Newsfile Corp. - April 28, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") today announced that its wholly-owned subsidiary Albany Graphite Corp. ("AGC......

28.04.26 - 10:03	Corporate News: Daiichi Sankyo Deutschland GmbH (EQS)
	Helden in der Patientenstärkung ausgezeichnet: Daiichi Sankyo verleiht O-Mamori Award 2026...

28.04.26 - 07:24	Otsuka Holdings Co., Ltd. Reveals Climb In Q1 Profit (AFX)
	TOKYO (dpa-AFX) - Otsuka Holdings Co., Ltd. (OTSKF) revealed a profit for its first quarter that Increased, from the same period last yearThe company's bottom line came in at JPY98.348 billion, or......

27.04.26 - 20:39	Astellas Pharma ADR GAAP EPS of JPY 162.22, revenue of JPY 2139.2B (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

27.04.26 - 18:31	Astellas Pharma meldet Rekordumsatz – Anleger blicken dennoch skeptisch in die Zukunft (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.04.26 - 09:12	Astellas Pharma Inc. Profit Rises In Full Year (AFX)
	TOKYO (dpa-AFX) - Astellas Pharma Inc. (ALPMY) announced earnings for its full year that Increased, from the same period last yearThe company's earnings came in at JPY291.535 billion, or JPY162.22......

24.04.26 - 22:00	ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? (Zacks)
	ADMA vs. Takeda: surging Asceniv demand boosts ADMA, but Takeda's diversified portfolio and stronger returns make it the steadier pick now....

24.04.26 - 17:12	Chugai Pharmaceutical meldet starkes Umsatzwachstum für Q1 2026, Aktie gibt dennoch nach (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.26 - 15:12	Chugai Pharmaceutical reports Q1 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.26 - 14:03	Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML (GlobeNewswire EN)
	– Regulatory Filing in Japan Planned Following Clinical Trial Completion – – Regulatory Filing in Japan Planned Following Clinical Trial Completion –...

>weitere News anzeigen...